ABSTRACT
Introduction
Lichen planus (LP) is a chronic and relatively common mucocutaneous disease and is considered a premalignant condition. It affects approximately 0.5-2% of the population worldwide. [1] Most of affected individuals are middle-aged and in their 4th decade of life but it may affect children and young adults either. Female-tomale ratio of affliction is 3:2 and the mean age of the diagnosis of the lesions is 55 years. [1] The etiology of oral lichen planus (OLP) is unknown. Over the years, a large mass of evidence has accumulated, indicating the primary role of the immune system in the development of this disease. [1] [2] Histopathological features in relation to the infiltration of T lymphocytes into the sub epithelial band and destruction of basal cells, referred to as liquefaction degeneration, confirms this postulation. [1] These characteristics can be interpreted as the immune system cell-mediated pathway emergence, with a role in the pathogenesis of the antigens exposed by the basal cell layer. [2] The immune system T lymphocytes might have an important initial role in the progression of OLP. These cells cannot make a distinction between the innate molecules of the body and foreign antigens. Activation of autoimmune T lymphocytes is a process that might move from oral mucosa to other parts of the body. It might even occur simultaneously with the initiation of mucosal lesions. [1] [2] Several treatments have been used for OLP; however, there is no definite treatment for this condition and various treatment modalities only relieve signs and symptoms. Therefore, widespread studies are still underway on the etiology and pathogenesis of the disease. Recent studies have shown that vitamin D has an endocrine effect an immune system cells, and exhibits anti inflammatory and regulatory effects on the immune system. [5] In addition, it has potential therapeutic effects on autoimmune diseases, psoriasis, and neoplasms. , and autoimmune gastritis. [7] In a study by El-Komy et al., [8] evaluation of vitamin D levels in patients with pemphigus vulgaris (PV) showed that these patients had lower vitamin D serum levels compared to healthy subjects. Vitamin D deficiency in patients with PV might exacerbate the disease through various immune system-related mechanisms.
[8] The results of a study by Joshi et al. [9] in Northern India on patients with PV were similar to those of aforementioned study.
The results of the studies conducted by Marzano et al. [10] [11] Data were analyzed with mean differences test in independent groups (independent samples t-test) or its non-parametric equivalent, using SPSS 17. Statistical significance was set at p< 0.05.
Results
Eighteen subjects were evaluated in the control group, consisting of female (77.8%) and male (22.2%) subjects. In the OLP group, 18 patients were evaluated, consisting of female (61.1%) and male (38.9%) subjects.
The mean age of the subjects in the control group was 49.94 years, with an age range of 21-76 years. The mean age of the subjects in the OLP group was 44.16 years, with an age range of 30-71 years.
The mean vitamin D serum levels in the OLP and control group subjects were 30.7±20.38 and 36.45± 15.33 (ng/mL), respectively, with a mean difference of 5.7 units, which was higher in the healthy subjects. Due to the homogeneity of variances in the two groups as evaluated by the Levene's test (p= 0.145), independent t-test was used to compare vitamin D serum levels between the healthy subjects and OLP patients, which showed no significant differences between the two groups (p= 0.346). The results of a study by Joshi et al. [9] in Northern India on 30 PV patients and 10 healthy subjects were consistent with those of the study by El-Komy et al. [8] They indicated that vitamin D insufficiency might a predisposing factor in PV and possibly exacerbates the disease through various immune related mechanisms that regulate T cell functions in vivo.
Discussion
A study by Silverberg et al. [16] showed that vitamin D serum levels in patients with vitiligo were less than normal levels. Vitiligo is a skin disorder in which the loss of the function of melanocytes creates nonpigmented areas on the skin. Although the etiology of the disorder is unknown, an autoimmune origin has been suggested for it in recent years. [16] The difference between the results of the our study and studies above might be attributed to ethnical, geographical differences, different techniques which used to measure serum vitamin D levels of the patients and nutrition status as a confounding factor.
In a study by Baldini et al., [17] the vitamin D serum levels in the patient with Sjögren's disease and healthy subjects were compared and the results showed no significant differences between the two groups, consistent with the results of the present study.
In a study by Moravvej et al. [18] on 52 pemphigus patients, data on demographics, body mass index, disease severity, and surface body area were obtained.
There was no significant association between vitamin D levels and presence of pemphigus, season of sampling, age, BMI, or smoking habit, consistent with the results of the present study. [18] In a study by Tukaj et al., [19] on 12 bullous pemphigoid patients, there was no significant difference in vitamin D serum levels between the healthy and affected subjects. They correlated their results to the different techniques employed to measure serum vitamin D levels of the patients (such as ELISA and radioimmunoassay) and the heterogeneity in disease activity i.e. active disease and clinical remission. [19] Evaluation of vitamin D serum levels in different forms of OLP and its relation to the severity of autoimmune diseases with larger samples is recommended for future studies.
Conclusion
The mean serum levels of vitamin D in patients with OLP were less than that in healthy subjects but the difference was not significant. This might be attributed to various factors affecting vitamin D serum levels, including sampling season, the duration of exposure to sunlight, BMI, age, the number of pregnancies, the serum levels of parathyroid hormone and the calcium serum level.
